Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px
Document › Details

Proteome Sciences plc. (5/31/16). "Press Release: Publication of Annual Report".

Organisations Organisation Proteome Sciences plc
  Group Proteome Sciences (Group)
  Organisation 2 Ikon Associates
Products Product TMT® (isobaric tandem mass tag) technology
  Product 2 PS Biomarker Services™
Person Person Pearce, Christopher (Proteome Sciences 201606– Non-executive Chairman before CEO)
     


The Company announces that its Annual Report and Accounts for the year ended 31 December 2015, together with a notice of the Annual General Meeting and accompanying form of proxy, are available to view on the Company’s website at www.proteomics.com, and will be posted to shareholders imminently.

[ Annual Report download at http://www.proteomics.com/docs/PS_AR_15_web-final-2.pdf ; iito ]


ENDS


For further information please contact:

Proteome Sciences plc
Christopher Pearce,
Executive Chairman
Dr. Ian Pike,
Chief Operating Officer
Tel: +44 (0)1932 865065
Geoff Ellis, Finance Director

finnCap Limited
(nominated adviser & broker)
Geoff Nash/James Thompson
Tel: +44 (0)20 7220 0500

Public Relations
IKON Associates
Email: adrian@ikonassociates.com
Adrian Shaw
Tel: +44 (0)1483 271291
Mobile +44(0)7979 900733


Notes for editors:


About Proteome Sciences plc (www.proteomics.com)

With its HQ in Cobham, UK and laboratory facilities in London and Frankfurt, Proteome Sciences is a global leader in applied proteomics offering high sensitivity, proprietary technologies and workflows in cell signalling pathways (SysQuant®, TMTcalibrator™) and in protein biomarker discovery, validation and assay development.

PS Biomarker Services® provides proteomics outsourcing services and proprietary biomarker assays from its ISO 9001:2008 facility in Frankfurt, Germany to pharmaceutical, biotechnology, diagnostics companies and academia.

Proteome Sciences’ research has discovered a large number of novel protein biomarkers in key human diseases with a focus mainly in neurological/neurodegenerative conditions and in cancer. It has patented blood biomarkers in Alzheimer’s disease, stroke, brain damage and cancers for diagnostic and treatment applications that are available for licenses.

   
Record changed: 2016-07-02

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px

More documents for Proteome Sciences (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA September 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px